What Halo Labs does

Halo Labs is a Philadelphia-based biotechnology instrumentation company founded in 2011 that develops the Aura platform, a line of analytical instruments used by biopharmaceutical companies for stability, quality, and safety assays during drug development research. The company's core product is a purpose-built hardware instrument line positioned for regulated pharmaceutical QC/QA workflows, and the company has secured adoption among major biopharmaceutical customers for these assay applications. No AI/ML, software-as-a-service, or recurring-software revenue streams are disclosed; the business is described as hardware sales of the Aura instrument line, with pricing not publicly disclosed.

The company operates a capital-efficient, early-stage commercialization model. Across multiple funding rounds since 2011 — including a $5.6M round in December 2018, a $12M Series B in April 2020, and a $6.99M Series C in July 2022 — Halo Labs has raised approximately $26M in total from a mix of life-science venture investors (BioAdvance, BroadOak Capital Partners, Research Corporation Technologies, Ben Franklin Technology Partners) and a strategic lead in Agilent Technologies. The Series C was earmarked for manufacturing capacity expansion and product development, indicating the company was scaling instrument production at the time of the round.

The organization is lean, with 11-50 employees, and is led technically by co-founder and CSO Bernardo Cordovez and SVP of Engineering Spencer Borg. Halo Labs sells to large biopharmaceutical customers through an enterprise field sales motion, and its only disclosed strategic commercial relationship is the Agilent-led Series C, which signals potential distribution or co-development leverage. Operating geographies, regulatory clearances, named customer logos, patents, awards, and product certifications are not disclosed in available sources.

Name

Halo Labs

Website

https://halolabs.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

Halo Labs is a Philadelphia-based biotechnology instrumentation company that develops the Aura platform — analytical instruments used by major biopharmaceutical companies for stability, quality, and safety assays in drug development research.

Ownership category

akta.pro rank

Headquarters

HQ city

Philadelphia

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Aura Instruments Sales: Sale of Aura analytical instruments to pharmaceutical companies for stability, quality, and safety testing in drug development research

Go-to-market motion1 record

Core offering

Halo Labs develops and sells the Aura platform, a line of analytical instruments used by biopharmaceutical companies to perform stability, quality, and safety assays in pharmaceutical and drug development research. The instruments support analytical workflows at major biopharmaceutical companies for pharmaceutical testing applications.

Product overview

Halo Labs offers the Aura platform, a unified product line of analytical instruments designed for pharmaceutical research applications. The platform focuses on stability, quality, and safety assays, providing a comprehensive solution for biopharmaceutical testing needs. The company's instruments have been adopted by major biopharmaceutical companies for their analytical workflows.

Differentiator

Problem solved

Functional benefit

Products and services

• Aura Platform Aura is a unified product line of analytical instruments designed for pharmaceutical research applications. The instruments are used by major biopharmaceutical companies to perform stability, quality, and safety assays in drug development research workflows.

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Malvern Panalytical: A leading analytical instrumentation company specializing in particle characterization, light scattering, and stability/QC measurements for biologics — directly comparable to Halo Labs' Aura platform.
• Beckman Coulter Life Sciences: Part of Danaher, Beckman Coulter offers particle analysis and analytical instruments used in pharmaceutical QC and stability workflows — directly comparable to Halo Labs' biopharma assay focus.
• Wyatt Technology: Specializes in light scattering and biophysical characterization instruments for biologics development, including stability and particle analysis — overlapping with Halo Labs' Aura analytical use cases.
• NanoSight (Malvern Panalytical): Nanoparticle tracking analysis line within Malvern Panalytical for subvisible particle characterization in biologics — directly comparable to Halo Labs' particle/stability assay focus.

Broad incumbents

• Agilent Technologies: Global analytical instrument leader and lead Series C investor in Halo Labs; offers broad biopharma analytical platforms that overlap with Aura's stability/QC workflow positioning.
• Thermo Fisher Scientific: Diversified life-science instrumentation and consumables giant whose pharma services and analytical instrument division overlaps with Halo Labs' biopharma QC assay focus.
• Sartorius AG: Provides bioprocess and analytics instruments for biologics manufacturing, including QC-relevant analytical tools — comparable to Halo Labs' positioning around biologics stability and safety assays.
• Molecular Devices (Danaher): Microplate-based detection and analytical instruments used across pharmaceutical research and QC — adjacent comparable to Aura's analytical instrumentation category.

Emerging players

• ProteinSimple (Bio-Techne): Specialized biopharma analytical instruments for protein and biologics characterization, with similar scientific depth and targeted enterprise pharma go-to-market as Halo Labs.
• Unchained Labs: Focused analytical instrumentation vendor for biologics development and manufacturing QC — comparable specialty positioning in biopharma assay workflows.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/halolabs_bmi

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds10 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Halo Labs